Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer - Jeitany, Maya; Leroy, Cédric; Tosti, Priscillia; Lafitte, Marie; Le Guet, Jordy; Simon, Valérie; Bonenfant, Debora; Robert, Bruno; Grillet, Fanny; Mollevi, Caroline; El Messaoudi, Safia; Otandault, Amaëlle; et al. (EMBO molecular medicine, 2018)
Keywords: Animals; Cellular Biology; collagen receptor; colorectal cancer; Colorectal Neoplasms - metabolism; Colorectal Neoplasms - pathology; Discoidin Domain Receptor 1 - genetics; Discoidin Domain Receptor 1 - metabolism; EMBO03; EMBO12; EMBO28; HCT116 Cells; HEK293 Cells; Humans; invasion; Life Sciences; Mice; Phosphoproteins - metabolism; Protein-Tyrosine Kinases - genetics; Protein-Tyrosine Kinases - metabolism; Proto-Oncogene Proteins c-bcr - genetics; Proto-Oncogene Proteins c-bcr - metabolism; Pyrimidines - pharmacology; Receptors, Collagen - genetics; Receptors, Collagen - metabolism; Research Article; Signal Transduction - drug effects; Signal Transduction - genetics; targeted therapy; tyrosine kinase; targeted therapy; colorectal cancer; invasion; collagen receptor; tyrosine kinase; Digestive System; Pharmacology & Drug Discovery; tyrosine kinase Subject Categories Cancer